The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer
Open accessAbstract
In the last decades, a lot of attention has been paid to the compounds present in medicinal Cannabis sativa L., such as Δ 9-tetrahydrocannabinol (Δ 9-THC) and cannabidiol (CBD), and their effects on inflammation and cancer-related pain. The National Cancer Institute (NCI) currently recognizes medicinal C. sativa as an effective treatment for providing relief in a number of symptoms associated with cancer, including pain, loss of appetite, nausea and vomiting, and anxiety. Several studies have described CBD as a multitarget molecule, acting as an adaptogen, and as a modulator, in different ways, depending on the type and location of disequilibrium both in the brain and in the body, mainly interacting with specific receptor proteins CB 1 and CB 2. CBD is present in both medicinal and fibre-type C. sativa plants, but, unlike Δ 9-THC, it is completely nonpsychoactive. Fibre-type C. sativa (hemp) differs from medicinal C. sativa, since it contains only few levels of Δ 9-THC and high levels of CBD and related nonpsychoactive compounds. In recent years, a number of preclinical researches have been focused on the role of CBD as an anticancer molecule, suggesting CBD (and CBD-like molecules present in the hemp extract) as a possible candidate for future clinical trials. CBD has been found to possess antioxidant activity in many studies, thus suggesting a possible role in the prevention of both neurodegenerative and cardiovascular diseases. In animal models, CBD has been shown to inhibit the progression of several cancer types. Moreover, it has been found that coadministration of CBD and Δ 9-THC, followed by radiation therapy, causes an increase of autophagy and apoptosis in cancer cells. In addition, CBD is able to inhibit cell proliferation and to increase apoptosis in different types of cancer models. These activities seem to involve also alternative pathways, such as the interactions with TRPV and GRP55 receptor complexes. Moreover, the finding that the acidic precursor of CBD (cannabidiolic acid, CBDA) is able to inhibit the migration of breast cancer cells and to downregulate the proto-oncogene c-fos and the cyclooxygenase-2 (COX-2) highlights the possibility that CBDA might act on a common pathway of inflammation and cancer mechanisms, which might be responsible for its anticancer activity. In the light of all these findings, in this review we explore the effects and the molecular mechanisms of CBD on inflammation and cancer processes, highlighting also the role of minor cannabinoids and noncannabinoids constituents of Δ 9-THC deprived hemp.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
The orphan receptor GPR55 is a novel cannabinoid receptor
Ryberg, E., Larsson, N., Sjögren, S., Hjorth, S., Hermansson, N., Leonova, J., Elebring, T., Nilsson, K., Drmota, T., & Greasley, P. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707460 · Cited by 1,568
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544 · cited 10×
“In the ambit of monoterpenes, β-myrcene is known to possess antiinflammatory, analgesic, and anxiolytic properties [2].”
BackgroundInfluentialBisogno, T., Hanuš, L., De Petrocellis, L., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Di Marzo, V. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,311
Inflammation and cancer: advances and new agents
Crusz, S. M., & Balkwill, F. R. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.105 · Cited by 1,184
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094
Beta-caryophyllene is a dietary cannabinoid.
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906
Phytocannabinoids: a unified critical inventory
Hanuš, L. O., Meyer, S. M., Muñoz, E., Taglialatela-Scafati, O., & Appendino, G. (2016) · Natural Product Reports · doi:10.1039/c6np00074f · Cited by 844
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Inflammation: Gearing the journey to cancer
KUNDU, J., & SURH, Y. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.03.002 · Cited by 803
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Lauckner, J. E., Jensen, J. B., Chen, H.-Y., Lu, H.-C., Hille, B., & Mackie, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711278105 · Cited by 712
Galve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Neuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Mackie, K., Lai, Y., Westenbroek, R., & Mitchell, R. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06552.1995 · Cited by 626
Cannabidiol: State of the art and new challenges for therapeutic applications
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., et al. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.041 · Cited by 614
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.059 · Cited by 573
Ligresti, A., Moriello, A. S., Starowicz, K., Matias, I., Pisanti, S., De Petrocellis, L., Laezza, C., Portella, G., Bifulco, M., & Di Marzo, V. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105247 · Cited by 568
Cannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555
Id family of helix-loop-helix proteins in cancer
Perk, J., Iavarone, A., & Benezra, R. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1673 · Cited by 535
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Shrivastava, A., Kuzontkoski, P. M., Groopman, J. E., & Prasad, A. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1100 · Cited by 449
Cannabidiol, neuroprotection and neuropsychiatric disorders
Campos, A. C., Fogaça, M. V., Sonego, A. B., & Guimarães, F. S. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.033 · Cited by 446
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Casanova, M., Blázquez, C., Martínez‐Palacio, J., Villanueva, C., Fernández‐Aceñero, M. J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16116 · Cited by 437
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Gelders, G., Baekelandt, V., & Van der Perren, A. (2018) · Journal of Immunology Research · doi:10.1155/2018/4784268 · Cited by 430
Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Sánchez, C., CEBALLOS, M. L. D., del Pulgar, T. G., Rueda, D., Corbacho, C., Velasco, G., Galve‐Roperh, I., Huffman, J. W., y Cajal, S. R., & Guzmán, M. (2001) · Cancer Research · Cited by 422
Esposito, G., Scuderi, C., Valenza, M., Togna, G. I., Latina, V., De Filippis, D., Cipriano, M., Carratù, M. R., Iuvone, T., & Steardo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028668 · Cited by 410 · cited 1×
“In cultured rat primary astrocytes, CBD has reduced the Aβ-induced release of NO, IL-1β, and TNF-α, by activating PPARγ and inhibitingNF-κBnuclear translocation [76].”
BackgroundMartín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N., Cuadrado, A., & de Ceballos, M. L. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071290 · Cited by 398
Qin, N., Neeper, M. P., Liu, Y., Hutchinson, T. L., Lubin, M. L., & Flores, C. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0504-08.2008 · Cited by 396
Sawzdargo, M., Nguyen, T., Lee, D. K., Lynch, K. R., Cheng, R., Heng, H. H. Q., George, S. R., & O'Dowd, B. F. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00277-0 · Cited by 378
Maresz, K., Pryce, G., Ponomarev, E. D., Marsicano, G., Croxford, J. L., Shriver, L. P., Ledent, C., Cheng, X., Carrier, E. J., Mann, M. K., et al. (2007) · Nature Medicine · doi:10.1038/nm1561 · Cited by 363
Carracedo, A., Gironella, M., Lorente, M., Garcia, S., Guzmán, M., Velasco, G., & Iovanna, J. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0169 · Cited by 354
Antineoplastic Activity of Cannabinoids2
Munson, A. E., Harris, L. S., Friedman, M. A., Dewey, W. L., & Carchman, R. A. (1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.3.597 · Cited by 348
Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Battista, G., Pagano, E., Di Marzo, V., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.017 · Cited by 326
Effector T Cells in Multiple Sclerosis
Kaskow, B. J., & Baecher-Allan, C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029025 · Cited by 314
Cannabinoid receptors as novel targets for the treatment of melanoma
Blázquez, C., Carracedo, A., Barrado, L., José Real, P., Luis Fernández‐Luna, J., Velasco, G., Malumbres, M., Guzmán, M., Blázquez, C., Carracedo, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 292
Kozela, E., Pietr, M., Juknat, A., Rimmerman, N., Levy, R., & Vogel, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069294 · Cited by 286
De Backer, B., Debrus, B., Lebrun, P., Theunis, L., Dubois, N., Decock, L., Verstraete, A., Hubert, P., & Charlier, C. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.11.004 · Cited by 285
Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
Tanaka, K., Babic, I., Nathanson, D., Akhavan, D., Guo, D., Gini, B., Dang, J., Zhu, S., Yang, H., De Jesus, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0124 · Cited by 275
Cannabinoid receptors and endocannabinoids: Evidence for new players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1007/bf02854900 · Cited by 275
Atypical Responsiveness of the Orphan Receptor GPR55 to Cannabinoid Ligands
Kapur, A., Zhao, P., Sharir, H., Bai, Y., Caron, M. G., Barak, L. S., & Abood, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.050187 · Cited by 274
Brighenti, V., Pellati, F., Steinbach, M., Maran, D., & Benvenuti, S. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.05.049 · Cited by 267
Self-citationRajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszar, A., Ungvari, Z., Mackie, K., Chatterjee, S., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 260
Nabissi, M., Morelli, M. B., Santoni, M., & Santoni, G. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs328 · Cited by 248
Costa, B., Colleoni, M., Conti, S., Parolaro, D., Franke, C., Trovato, A. E., & Giagnoni, G. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-004-0871-3 · Cited by 242
Elbaz, M., Nasser, M. W., Ravi, J., Wani, N. A., Ahirwar, D. K., Zhao, H., Oghumu, S., Satoskar, A. R., Shilo, K., Carson, W. E., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.010 · Cited by 232
McAllister, S. D., Murase, R., Christian, R. T., Lau, D., Zielinski, A. J., Allison, J., Almanza, C., Pakdel, A., Lee, J., Limbad, C., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1177-4 · Cited by 229
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
Watt, G., & Karl, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00020 · Cited by 227
Chang, Y., Lee, S. T., & Lin, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1103 · Cited by 219
The Cannabinoid System and Cytokine Network
Klein, T. W., Lane, B., Newton, C. A., & Friedman, H. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 214
Yoon, W.-J., Lee, N. H., & Hyun, C.-G. (2010) · Journal of Oleo Science · doi:10.5650/jos.59.415 · Cited by 211
GPR55 ligands promote receptor coupling to multiple signalling pathways
Henstridge, C. M., Balenga, N. A., Schröder, R., Kargl, J. K., Platzer, W., Martini, L., Arthur, S., Penman, J., Whistler, J. L., Kostenis, E., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00625.x · Cited by 209
Cannabinoids: Occurrence and Medicinal Chemistry
Appendino, G., Chianese, G., & Taglialatela-Scafati, O. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794940888 · Cited by 208
Vanilloid Transient Receptor Potential Cation Channels: An Overview
Nilius, B., Vennekens, R., & Owsianik, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783330763 · Cited by 199
Cannabis Phenolics and their Bioactivities
Pollastro, F., Minassi, A., & Fresu, L. G. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666170810164636 · Cited by 198
New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp)
Pellati, F., Brighenti, V., Sperlea, J., Marchetti, L., Bertelli, D., & Benvenuti, S. (2018) · Molecules · doi:10.3390/molecules23102639 · Cited by 198
Self-citationWhat do we know about the transient receptor potential vanilloid 2 (TRPV 2) ion channel?
Perálvarez‐Marín, A., Doñate‐Macian, P., & Gaudet, R. (2013) · The FEBS Journal · doi:10.1111/febs.12302 · Cited by 184
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
Andradas, C., Caffarel, M. M., Pérez-Gómez, E., Salazar, M., Lorente, M., Velasco, G., Guzmán, M., & Sánchez, C. (2011) · Oncogene · doi:10.1038/onc.2010.402 · Cited by 183
Cianchi, F., Papucci, L., Schiavone, N., Lulli, M., Magnelli, L., Vinci, M. C., Messerini, L., Manera, C., Ronconi, E., Romagnani, P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0799 · Cited by 181
The Role of CD4 T Cells in the Pathogenesis of Multiple Sclerosis
Chitnis, T. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)79003-7 · Cited by 173
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis
De Filippis, D., Esposito, G., Cirillo, C., Cipriano, M., De Winter, B. Y., Scuderi, C., Sarnelli, G., Cuomo, R., Steardo, L., De Man, J. G., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028159 · Cited by 173
Cannabinoids and cancer: pros and cons of an antitumour strategy
Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706632 · Cited by 173
Petrosino, S., Verde, R., Vaia, M., Allarà, M., Iuvone, T., & Marzo, V. D. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.244368 · Cited by 173
Targeting the endocannabinoid system in cancer therapy: A call for further research
Bifulco, M., & Di Marzo, V. (2002) · Nature Medicine · doi:10.1038/nm0602-547 · Cited by 172
Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair
Vivekanantham, S., Shah, S., Dewji, R., Dewji, A., Khatri, C., & Ologunde, R. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2014.982795 · Cited by 171
Izzo, A. A., Capasso, R., Aviello, G., Borrelli, F., Romano, B., Piscitelli, F., Gallo, L., Capasso, F., Orlando, P., & Di Marzo, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01879.x · Cited by 168
Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
Wang, D., Wang, H., Ning, W., Backlund, M. G., Dey, S. K., & DuBois, R. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0896 · Cited by 166
Scuderi, C., Steardo, L., & Esposito, G. (2014) · Phytotherapy Research · doi:10.1002/ptr.5095 · Cited by 161
Ruhaak, L. R., Felth, J., Karlsson, P. C., Rafter, J. J., Verpoorte, R., & Bohlin, L. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.774 · Cited by 160
Solinas, M., Massi, P., Cinquina, V., Valenti, M., Bolognini, D., Gariboldi, M., Monti, E., Rubino, T., & Parolaro, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076918 · Cited by 159
DiPatrizio, N. V. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0001 · Cited by 158
Amantini, C., Ballarini, P., Caprodossi, S., Nabissi, M., Morelli, M. B., Lucciarini, R., Cardarelli, M. A., Mammana, G., & Santoni, G. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp138 · Cited by 157
Maccarrone, M., Valensise, H. C. C., Bari, M., Lazzarin, N., Romaninï, C., & Finazzi‐Agrò, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7183 · Cited by 155
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149 · cited 1×
“CBDA has antimicrobial and antinausea properties [1, 11, 13], while CBG has anti-inflammatory, antimicrobial, and analgesic activities [1, 11, 13, 15].”
BackgroundCannabinoid Receptors and Endocannabinoids: Evidence for New Players
Mackie, K., & Stella, N. (2006) · The AAPS Journal · doi:10.1208/aapsj080234 · Cited by 149
The Epidermal Growth Factor Receptor: A Link Between Inflammation and Liver Cancer
Berasain, C., Perugorria, M. J., Latasa, M. U., Castillo, J., Goñi, S., Santamaría, M., Prìeto, J., & Avila, M. A. (2009) · Experimental Biology and Medicine · doi:10.3181/0901-mr-12 · Cited by 144
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 141
Cannabinoids mediate opposing effects on inflammation‐induced intestinal permeability
Alhamoruni, A., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01589.x · Cited by 138
Prospects for cannabinoid therapies in basal ganglia disorders
Fernández‐Ruíz, J., Moreno‐Martet, M., Rodríguez‐Cueto, C., Palomo‐Garo, C., Gómez‐Cañas, M., Valdeolivas, S., Guaza, C., Romero, J., Guzmán, M., Mechoulam, R., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01365.x · Cited by 136
Effects of pro‐inflammatory cytokines on cannabinoid CB 1 and CB 2 receptors in immune cells
Jean-Gilles, L., Braitch, M. K., Latif, M. L., Aram, J., Fahey, A. J., Edwards, L. J., Robins, R. A., Tănăsescu, R., Tighe, P. J., Gran, B., et al. (2015) · Acta Physiologica · doi:10.1111/apha.12474 · Cited by 136
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Pérez-Gómez, E., Andradas, C., Blasco-Benito, S., Caffarel, M. M., García-Taboada, E., Villa‐Morales, M., Moreno, E., Hamann, S., Martín-Villar, E., Flores, J. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv077 · Cited by 135
Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice
Berdyshev, E. V., Boichot, E., Corbel, M., Germain, N., & Lagente, V. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00324-5 · Cited by 134
In Vitro Model of Neuroinflammation: Efficacy of Cannabigerol, a Non-Psychoactive Cannabinoid
Gugliandolo, A., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071992 · Cited by 132
Werz, O., Seegers, J., Schaible, A. M., Weinigel, C., Barz, D., Koeberle, A., Allegrone, G., Pollastro, F., Zampieri, L., Grassi, G., et al. (2014) · PharmaNutrition · doi:10.1016/j.phanu.2014.05.001 · Cited by 131 · cited 2×
“sativa constituents, cannflavins anti-inflammatory activity has been poorly investigated, but it seems to be related to the reduction of PGE 2 and the inhibition of 5-lipoxygenase [18, 46].”
BackgroundJamontt, J., Molleman, A., Pertwee, R. G., & Parsons, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00791.x · Cited by 129
Janefjord, E., Mååg, J. L. V., Harvey, B. S., & Smid, S. D. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9984-x · Cited by 118
Watzl, B., Scuderi, P., & WATSON, R. R. (1991) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(91)90160-9 · Cited by 111
Pérez-Gómez, E., Andradas, C., Flores, J. M., Quintanilla, M., Paramio, J. M., Guzmán, M., & Sánchez, C. (2012) · Oncogene · doi:10.1038/onc.2012.278 · Cited by 111
Jia, W., Hegde, V. L., Singh, N. P., Sisco, D., Grant, S., Nagarkatti, M., & Nagarkatti, P. S. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0193 · Cited by 110
Ben‐Shabat, S., Hanuš, L. O., Katzavian, G., & Gallily, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050709m · Cited by 109
Endocannabinoid‐like N‐arachidonoyl serine is a novel pro‐angiogenic mediator
Zhang, X., Maor, Y., Jf, W., Kunos, G., & Groopman, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00841.x · Cited by 108
Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs
Dumitru, C. A., Sandalcioglu, I. E., & Karsak, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00159 · Cited by 107
Oka, S., Kimura, S., Toshida, T., Ota, R., Yamashita, A., & Sugiura, T. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvp208 · Cited by 105
Mukhopadhyay, B., Schuebel, K. E., Mukhopadhyay, P., Çınar, R., Godlewski, G., Xiong, K., Mackie, K., Lizak, M. J., Yuan, Q., Goldman, D. A., et al. (2015) · Hepatology · doi:10.1002/hep.27686 · Cited by 103
Chiurchiù, V., Lanuti, M., Bardi, M. D., Battistini, L., & Maccarrone, M. (2014) · International Immunology · doi:10.1093/intimm/dxu097 · Cited by 103
Transient Receptor Potential Type Vanilloid 1 Suppresses Skin Carcinogenesis
Bode, A. M., Cho, Y., Zheng, D., Zhu, F., Ericson, M. E., Ma, W.-Y., Yao, K., & Dong, Z. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3263 · Cited by 102
Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon
Couch, D. G., Tasker, C., Theophilidou, E., Lund, J. N., & O’Sullivan, S. E. (2017) · Clinical Science · doi:10.1042/cs20171288 · Cited by 98
Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation
McCoy, K. L. (2016) · Mediators of Inflammation · doi:10.1155/2016/5831315 · Cited by 96
Guo, K., Mou, X., Huang, J., Xiong, N., & Li, H. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0243-5 · Cited by 92
TRPV Channels in Tumor Growth and Progression
Santoni, G., Farfariello, V., & Amantini, C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_49 · Cited by 86
Isolation from cannabis sativa L. of cannflavin—a novel inhibitor of prostaglandin production
Barrett, M. L., Gordon, D., & Evans, F. J. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90325-9 · Cited by 83 · cited 1×
“sativa constituents, cannflavins anti-inflammatory activity has been poorly investigated, but it seems to be related to the reduction of PGE 2 and the inhibition of 5-lipoxygenase [18, 46].”
BackgroundCannabidiol Reverses Deficits in Hippocampal LTP in a Model of Alzheimer’s Disease
Hughes, B., & Herron, C. E. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2513-z · Cited by 79
Insights into Ca2+ homeostasis of advanced prostate cancer cells
Flourakis, M., & Prevarskaya, N. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.009 · Cited by 78
Lombard, C. A., Nagarkatti, M., & Nagarkatti, P. S. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.01.014 · Cited by 77
Thors, L., Bergh, A. R. J., Persson, E., Hammarsten, P., Stattin, P. E., Egevad, L., Granfors, T., & Fowler, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012275 · Cited by 75
Antitumorigenic effects of cannabinoids beyond apoptosis.
Freimuth, N., Ramer, R., & Hinz, B. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157735 · Cited by 71
Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis
Hunter, S. A., & BURSTEIN, S. H. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00122-7 · Cited by 70
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
Messalli, E. M., Grauso, F., Luise, R., Angelini, A., & Rossiello, R. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.04.004 · Cited by 66
Koudriavtseva, T., & Mainero, C. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.194804 · Cited by 65
Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
Cordier-Dirikoc, S., Priola, S. A., Marella, M., Zsürger, N., & Chabry, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1942-07.2007 · Cited by 62
Rubio‐Araiz, A., Arévalo‐Martín, Á., Gómez, O., Navarro‐Galve, B., García‐Ovejero, D., Suetterlin, P., Sánchez-Heras, E., Molina‐Holgado, E., & Molina‐Holgado, F. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.03.010 · Cited by 56
Down-regulation of cyclooxygenase-2 (COX-2) by cannabidiolic acid in human breast cancer cells
Takeda, S., Okazaki, H., Ikeda, E., Abe, S., Yoshioka, Y., Watanabe, K., & Aramaki, H. (2014) · The Journal of Toxicological Sciences · doi:10.2131/jts.39.711 · Cited by 54
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells
Arnold, J. C., Hone, P., Holland, M. L., & Allen, J. D. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70871-x · Cited by 50
Sido, J. M., Jackson, A. R., Nagarkatti, P. S., & Nagarkatti, M. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1404-5 · Cited by 50
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
Jung, C. K., Kang, W. K., Park, J. M., Ahn, H. J., Kim, S. W., Oh, S. T., & Choi, K. Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.1081 · Cited by 46
Δ9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines
Shivers, S. C., Newton, C. A., Friedman, H. P., & Klein, T. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00856-6 · Cited by 44
Gigli, S., Seguella, L., Pesce, M., Bruzzese, E., D’Alessandro, A., Cuomo, R., Steardo, L., Sarnelli, G., & Esposito, G. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617698622 · Cited by 44
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management
DeMorrow, S., & Leyva-Illades (2013) · Cancer Management and Research · doi:10.2147/cmar.s35175 · Cited by 38
Allegrone, G., Pollastro, F., Magagnini, G., Taglialatela-Scafati, O., Seegers, J., Koeberle, A., Werz, O., & Appendino, G. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b01126 · Cited by 36
Roth, M. D., Castaneda, J. T., & Kiertscher, S. M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9587-z · Cited by 36
Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma
Benz, A. H., Renné, C., Maronde, E., Koch, M., Hohmann, U., Kallendrusch, S., Rengstl, B., Newrzela, S., Hartmann, S., Hansmann, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081675 · Cited by 32
Medicinal cannabis in oncology
Engels, F. K., de Jong, F. A., Mathijssen, R. H. J., Erkens, J. A., Herings, R. M. C., & Verweij, J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.09.010 · Cited by 27
Chemical Composition and In Vitro Neuroprotective Activity of Fibre-Type Cannabis sativa L. (Hemp)
Corsi, L., Pellati, F., Brighenti, V., Plessi, N., & Benvenuti, S. (2018) · Current Bioactive Compounds · doi:10.2174/1573407214666180809124952 · Cited by 25
Self-citationNgaotepprutaram, T., Kaplan, B. L. F., & Kaminski, N. E. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.08.023 · Cited by 23
Cannabis sativa L. Constituents and Their Role in Neuroinflammation
Borgonetti, V., Governa, P., Montopoli, M., & Biagi, M. (2019) · Current Bioactive Compounds · doi:10.2174/1573407214666180703130525 · Cited by 16
Self-citationFijał, K., & Filip, M. (2016) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000132 · Cited by 11
Cited by
Antioxidative and Anti-Inflammatory Properties of Cannabidiol
Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019) · Antioxidants · doi:10.3390/antiox9010021 · Cited by 818
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Rupasinghe, H. P. V., Davis, A., Kumar, S. K., Murray, B., & Zheljazkov, V. D. (2020) · Molecules · doi:10.3390/molecules25184078 · Cited by 260
Hydrothermal and mechanically generated hemp hurd nanofibers for sustainable barrier coatings/films
Tyagi, P., Gutierrez, J. N., Nathani, V., Lucia, L. A., Rojas, O. J., Hubbe, M. A., & Pal, L. (2021) · Industrial Crops and Products · doi:10.1016/j.indcrop.2021.113582 · Cited by 56
Kobus, Z., Pecyna, A., Buczaj, A., Krzywicka, M., Przywara, A., & Nadulski, R. (2022) · Applied Sciences · doi:10.3390/app12136747 · Cited by 39
Metadata
- Authors
- Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2018-12-04
- Volume
- 2018
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2902363655
- Cited by
- 371
- References
- 129
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.